We’re on a mission to bring the newest clinical trials to as many people with cancer and chronic illnesses as possible, as close to home as possible. We strongly believe clinical trials should be available to everyone.
We are working hard to expand our research locations across Australia, reaching those affected by cancer in outer-metro and regional areas.
Research and clinical trials at Icon Cancer Foundation
At Icon Cancer Foundation (ICF), we fund vital clinical trials and research, improving cancer care and helping us find new, better and safer treatments for patients.
We support independent, investigator-initiated research led by researchers and clinicians across the Icon Cancer Centre network. Through these trials, we evaluate innovative new therapies in real-world settings.
Our research helps answer key questions:
Does this treatment work?
Is there a better treatment option than what’s already available?
Are there any side effects?
How can we improve the quality of life for patients?
By supporting ICF, you’re backing a team of researchers across Australia who work tirelessly for people with cancer.
Our goal is to build Australia’s leading private cancer research program — expanding access to innovative trials, closer to home, for as many patients as possible.
Active clinical trials supported by Icon Cancer Foundation
COMPRES
Evaluates use of compression therapy to help prevent and reduce oxaliplatin-induced peripheral neuropathy side effects.
Locations: Hobart
Diagnosis: Oxaliplatin-induced peripheral neuropathy
PUMA
Randomised non-inferiority trial investigating patient-reported outcomes from partial breast irradiation (PBI) using external beam volumetric modulated arc therapy (VMAT).
Locations: Windsor Gardens, Wahroonga, Hobart, Toowoomba
Diagnosis: Breast cancer
ROSEND
A randomised trial for the treatment of recalcitrant symptomatic rosacea using definitive volumetric modulated arc radiotherapy or standard dermatological treatment.
Locations: Gosford
Diagnosis: Rosacea
TREMOR
Safety and effectiveness of frameless linac-based stereotactic radiosurgery on tremor in patients with essential tremor or Parkinson’s disease.
Locations: Epworth Richmond
Diagnosis: Neurological conditions
Upcoming clinical trials
Additional trials are in development and will be available to patients in the future.
iROAR
Diagnosis: Osteoarthritis
Investigators: Associate Professor Peter Gorayski and Lydia Tamblyn
Past clinical trials
LIBERATE
Clinical registry of focal low dose rate brachytherapy in men with biopsy confirmed low-intermediate risk prostate cancer.
Status: Monitoring
Diagnosis: Prostate Cancer
Investigators: Dr Andrew See and Dr Eve Tiong
TRANSFORM
Stereotactic radiation therapy (SRT) for men with metastatic prostate cancer.
Status: Monitoring
Diagnosis: Prostate Cancer
Investigators: Dr Patrick Bowden
More information
